Vaccines for the New Millennium Act of 2001
Latest action · May 16, 2001 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 16, 2001
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.
Establishes the Lifesaving Vaccine Purchase Fund.
Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from May 16, 2001 to Nov 5, 2001; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-TN | William H. Frist | Original | May 16, 2001 |
| I-CT | Joseph I. Lieberman | Nov 5, 2001 | |
| D-WA | Patty Murray | Nov 5, 2001 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred May 16, 2001 |
Actions 3
Everything that happened, newest first.
- May 16, 2001Introduced in Senate
- May 16, 2001Sponsor introductory remarks on measure. (CR S5008-5009)
- May 16, 2001Read twice and referred to the Committee on Finance.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S5008–S5010Summaries S5010 | John F. Kerry D-MA, William H. Frist R-TN | May 16, 2001 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Internal Revenue Code of 1986 to allow a credit against income tax for research related to developing vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed.
- Short Titles as Introduced
- Vaccines for the New Millennium Act of 2001
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
- Access to health care
- AIDS (Disease)
- Biotechnology
- Business and social problems
- Business income tax
- Clinical trials
- Commerce
- Communicable diseases
- Congress
- Congressional reporting requirements
- Developing countries
- Drug industry
- Economics and Public Finance
- Government and business
- Government Operations and Politics
- Government trust funds
- Governmental investigations
- Health
- Human immunodeficiency viruses
- Income tax
- Intellectual property
- International Affairs
- International agencies
- International cooperation
- Malaria
- Medical research
- Microbiological research
- Nongovernmental organizations
- Nonprofit organizations
- Patents
- Pharmaceutical research
- Prescription pricing
- Price policy
- Research and development tax credit
- Science, Technology, Communications
- Social Welfare
- Tax deductions
- Taxation
- Technology transfer
- Trade secrets
- Tuberculosis
- Vaccines
- World health
Text 1
Each version as it was printed, newest first.
- May 16, 2001Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.